General Medicine
Intravenous Artesunate for Malaria
$10.00
Universal Activity Number: 407-000-10-021-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 07/01/2010
Expiration date: 07/01/2013
CEUs 0.1
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 07/01/2010
Expiration date: 07/01/2013
Article title:
view more on 407-000-10-021-H01-P
Intravenous Artesunate for the Treatment of Severe Malaria
Drugs used for Diabetes
$8.00
Universal Activity Number: 407-000-10-058-H01-T
CEUs 1.0
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 05/01/2010
Expiration date: 05/01/2013
CEUs 1.0
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 05/01/2010
Expiration date: 05/01/2013
Article title:
view more on 407-000-10-058-H01-T
Review of Medications Used in the Treatment of Diabetes Mellitus
Milnacipran
$8.00
Universal Activity Number: 407-000-10-053-H01-T
CEUs 1.0
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 05/01/2010
Expiration date: 05/01/2013
CEUs 1.0
Audience: Pharmacy Technicians
Activity Type: Knowledge-based
Issued date: 05/01/2010
Expiration date: 05/01/2013
Article title:
view more on 407-000-10-053-H01-T
Milnacipran: A New Treatment for Fibromyalgia Syndrome
Milnacipran
$8.00
Universal Activity Number: 407-000-10-053-H01-P
CEUs 1.0
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 05/01/2010
Expiration date: 05/01/2013
CEUs 1.0
Audience: Pharmacist
Activity Type: Knowledge-based
Issued date: 05/01/2010
Expiration date: 05/01/2013
Article title:
view more on 407-000-10-053-H01-P
Milnacipran: A New Treatment for Fibromyalgia Syndrome
Fesoterodine for OAB
$10.00
Universal Activity Number: 407-000-09-021-H01-P
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 12/01/2009
Expiration date: 12/01/2012
CEUs 0.1
Audience: Pharmacist
Activity Type: Application-based
Issued date: 12/01/2009
Expiration date: 12/01/2012
Article title:
view more on 407-000-09-021-H01-P
Fesoterodine for the Treatment of Overactive Bladder